article thumbnail

Transfusion Threshold in Myocardial Infarction: MINT Trial

American College of Cardiology

Hemoglobin (Hb) threshold for red cell transfusion in myocardial infarction (MI) with anemia has been a matter of debate. Previous randomized trials have not consistently shown a benefit of liberal transfusion strategy.

article thumbnail

Randomized Evaluation of Decreased Usage of Beta-Blockers After Acute Myocardial Infarction

American College of Cardiology

The goal of the REDUCE-AMI trial was to evaluate the potential benefit of beta-blockade following acute myocardial infarction (AMI) in patients with preserved left ventricular ejection fraction (LVEF) in the modern era of coronary revascularization and medical therapy.

article thumbnail

Occlusion myocardial infarction is a clinical diagnosis

Dr. Smith's ECG Blog

Occlusion myocardial infarction is a clinical diagnosis Written by Willy Frick (@Willyhfrick). St depression in lead AVL differentiates inferior st-elevation myocardial infarction from pericarditis. link] Opiates are associated with worse outcomes in Myocardial Infarction. Circulation , 130 (25). Worrall, C.,

article thumbnail

REDUCE-AMI: No Benefit to Beta Blockers Post-Myocardial Infarction If LVEF is Normal

HCPLive

REDUCE-AMI concluded beta-blockers show no significant benefit following myocardial infarction among patients with normal left ventricular ejection fraction

article thumbnail

Dual Antiplatelet Therapy De-Escalation After Myocardial Infarction With High Ischemic Risk

JAMA Cardiology

This post hoc analysis of the Ticagrelor vs Clopidogrel in Stabilized Patients With Acute Myocardial Infarction (TALOS-AMI) randomized clinical trial investigates the efficacy and safety of the de-escalation strategy of switching from ticagrelor to clopidogrel vs dual antiplatelet therapy with ticagrelor in stabilized patients with acute myocardial (..)

article thumbnail

Ticagrelor vs Clopidogrel in Stabilized Patients With Acute Myocardial Infarction

American College of Cardiology

The goal of the TALOS-AMI trial was to assess whether de-escalating dual antiplatelet therapy (DAPT) with clopidogrel rather than ticagrelor 1 month after percutaneous coronary intervention (PCI) for an acute myocardial infarction (AMI) would be a noninferior strategy.

article thumbnail

Multivessel Immediate vs. Staged Revascularization in Acute Myocardial Infarction: The MULTISTARS AMI Trial

American College of Cardiology

The MULTISTARS AMI (MULTivessel Immediate versus STAged RevaScularization in Acute Myocardial Infarction) trial compared immediate versus delayed percutaneous coronary intervention (PCI) of nonculprit lesions in patients with ST-segment elevation myocardial infarction (STEMI) who underwent successful primary PCI of the culprit lesion.